DOI: 10.33470/2379-9536.1366

CASE REPORT

Volume 8 Issue 3

A Case of Metastatic Melanoma Presenting as a Small
Bowel Obstruction
Micah S. Ray, MS1, Danielle Harris, D1,
Andrew J. Weaver, MD1, Stephen Wilson, MD1

ABSTRACT
Small bowel obstructions are most commonly caused by adhesion. Less common
causes arise from malignant pathology. Here, we present a relatively rare case of a small
bowel obstruction due to malignant melanoma. Melanoma involving the gastrointestinal tract is relatively rare, with most cases occurring as metastatic spread from a cutaneous primary. The treatment typically requires a surgical resection or palliative bypass.
When a patient presents with a small bowel obstruction without prior abdominal
surgeries or hernias, a malignant obstruction must be on the differential.
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INTRODUCTION

CASE REPORT

Melanoma is a relatively common neoplasm that
typically presents as a suspicious cutaneous lesion.
As such, most cases of metastatic melanoma have
a known primary lesion. Historically, metastatic
malignant melanoma was nearly universally deadly,
and more recent 5-year survival rates are still only
between 5 and 19%.1 Melanoma involving the
gastrointestinal tract has been reported from both
primary mucosal lesions and metastatic spread
from a distant lesion. Reported cases of malignant
melanoma spreading to the small intestines are
becoming more common, with an incidence rate of
approximately 35 to 50%.2 Other common sites for
cutaneous melanoma spread are the liver, lung, and
bone.

Our patient is an 81-year-old male with no prior
medical or surgical history. He presented through
the emergency department with colicky abdominal
pain, constipation, poor oral intake, and a 15-pound
weight loss. He did not have any symptoms of
melena or hematochezia. He rarely followed up with
his primary care doctor and had never undergone a
colonoscopy prior to this admission. His family history
was significant, with a father and uncle both having
been diagnosed with colon cancer in their mid to late
eighties.

Symptoms of metastatic melanoma to the
gastrointestinal tract are similar to any primary or
metastatic malignancy of the gastrointestinal tract;
it presents as obstruction, bleeding, or perforation.
It is important for surgeons to recognize metastatic
small bowel melanoma as a possible cause of bowel
obstruction, especially in patients with even a remote
history of melanoma.
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He was hemodynamically stable on presentation,
with a distended but soft abdomen. Laboratory
values were unremarkable. CT scan of his abdomen
and pelvis demonstrated a large 15x10 cm mass
in his pelvis, with questionable liver metastasis
(Figure 1). He was noted to have significant small
bowel dilatation with a transition point in his pelvis
consistent with small bowel obstruction.
The initial concern was for possible colon cancer.
GI was consulted, and the patient underwent a
colonoscopy. The scope was completed up to the

mds.marshall.edu/mjm
© 2022 Marshall Journal of Medicine

Marshall Journal of Medicine
Volume 8 Issue 3

splenic flexure but was not completed to the cecum
due to poor prep. No mucosal abnormalities were
appreciated.
A CT scan of his thorax was ordered to complete the
oncological workup with findings of a small nonspecific lung nodule. This nodule was reported as a

FIGURE 1. CT scan of abdomen and pelvis on initial presentation demonstrating obstructive mass.

FIGURE 2. Specimen from resection which included small
bowel, mesentery, and sigmoid colon.
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likely benign finding, but a metastatic lesion could
not be fully excluded. His CEA came back within
normal limits; CA 19-9 was elevated at 45 (0-35
normal).
As the patient was obstructed from this pelvic mass,
the decision was made on hospital day 2 to operate
with an exploratory laparotomy
and possible palliative bypass
vs. en bloc resection. Of note,
possible metastatic disease
was suspected. On physical
examination, the patient had
a small melanotic-appearing
skin lesion just inferior to his
right clavicle, approximately
2x2 cm. No other skin lesions,
ophthalmological pathology,
lymphadenopathy, rectal lesions,
or oral mucosal lesions were
noted on physical examination.
The patient underwent wedge
biopsy of the right sub-clavicular
skin lesion in the operating
room. Urology placed bilateral
ureteral stents in the operating
room. The patient then underwent an exploratory
laparotomy. After entering the abdomen, the mass
was easily identified, as shown in figure 2. This mass
appeared to originate from a loop
of the small bowel, invading the
mesentery and the sigmoid colon.
An en bloc resection of the mass
was performed, including the
involved small bowel, mesentery,
and sigmoid colon. The liver had
palpable irregularities, which were
also biopsied. The small bowel was
primarily anastomosed, and an end
colostomy was matured.
Pathology reports from the skin
wedge resection demonstrated
melanoma in-situ that was
negative for any intradermal/
invasive component. The liver
biopsy was consistent with
metastatic melanoma. The report from the en
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bloc resection demonstrated a mass involving the
small bowel and mesentery that was 13.5x10.5x7.9
cm. The mass stained positive for S100, HMB45,
MelanA, CD56, and CD 117 and was consistent with
metastatic melanoma. The mass had transmural
involvement of the small bowel and serosal
involvement of the sigmoid colon. Thirteen lymph
nodes were identified in the specimen and were all
negative for disease. The total length of the small
bowel resected was approximately 70 cm.

should be performed. In addition, all major lymph
node groups should be examined. In our patient,
the cutaneous lesion was the most likely source
of metastatic spread. Although our biopsy of the
cutaneous lesion returned as melanoma in-situ, it
is possible that either the lesion regressed, or we
missed the deepest part of the lesion on our wedge
biopsy. While re-excision of the lesion was discussed,
the result would not change the management of our
patient.

The patient did well postoperatively. He was a
motived patient with colostomy function on
postoperative day 2. His diet was advanced slowly
to a regular diet. He was discharged home on
postoperative day 6 and was followed up once
in clinic approximately 10 days after discharge.
He failed to return to subsequent follow-up
appointments.

Melanoma involving the GI tract is often diagnosed
late and typically presents as bowel obstruction,
bleeding, or perforation. Surgical removal with
tumor-free margins is the principal treatment option
for melanoma involving the small bowel. A wide
intestinal resection, including the resection of the
mesentery with lymph nodes, is the treatment of
choice.3 Surgical resection is effective in palliating
symptoms and may even prolong survival.4
Historically, adjuvant chemotherapy has had a
limited role in such cases, as response rates were
insignificant.5 Similarly, other treatment modalities,
such as immunotherapy and targeted therapies, also
had a limited role due to their low response rates.6
More recent advancements in chemotherapy and
immune therapy have shown promise in improved
survival rates, but more studies are needed on
managing these expanding treatment options.7

DISCUSSION
Melanoma found in the gastrointestinal tract is
relatively rare and is either of a primary mucosal
lesion or of metastatic origins. Of metastatic sources,
cutaneous melanoma most often metastasizes to
the gastrointestinal tract, with the small bowel being
a common site, owing to a rich blood supply. It has
been postulated that about 60% of patients who
die from metastatic melanoma are found to have
gastrointestinal metastases on autopsy.2 Persistent
non-specific complaints, such as vague abdominal
pain, weight loss, anorexia, or fatigue, should
lead to suspicion of melanoma metastases to the
gastrointestinal tract in patients who have even a
remote history of melanoma.
Distinguishing between a primary gastrointestinal
mucosal melanoma and a metastatic lesion from
an unknown or regressed primary lesion can be
difficult. If a melanotic lesion is found during an
endoscopic procedure or diagnosed postoperatively
by pathology, it is important to perform a thorough
physical exam to rule out a primary source. After
ruling out a cutaneous lesion as the primary
source, an ocular exam should be performed
as oculocutaneous lesions are the second most
common site of primary melanoma. After lesions
in the eye are ruled out, vaginal and rectal exams
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CONCLUSION
Malignant bowel obstruction must be part of the
differential diagnosis in a patient that presents
with small bowel obstructions without prior
abdominal surgeries or obvious hernias. Melanoma
is recognized as the most common extra-intestinal
malignancy to metastasize to the gastrointestinal
tract. Surgery still plays an important role in both
palliation and prolonging survival.
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